The Cancer Genome Atlas Program

The Cancer Genome Atlas (TCGA), a landmark cancer genomics program, molecularly characterized over 20,000 primary cancer and matched normal samples spanning 33 cancer types. This joint effort between the National Cancer Institute and the National Human Genome Research Institute began in 2006, bringing together researchers from diverse disciplines and multiple institutions.

Over the next dozen years, TCGA generated over 2.5 petabytes of genomic, epigenomic, transcriptomic, and proteomic data. The data, which has already lead to improvements in our ability to diagnose, treat, and prevent cancer, will remain publicly available for anyone in the research community to use.

TCGA Cancers Selected for Study

An overview of the 33 different cancers types TCGA selected for study and the criteria used to select them.

TCGA Computational Tools

Some of the data processing, visualization, and other computational tools developed by TCGA network researchers and collaborators.

Molecular Characterization Platforms

Descriptions and supporting materials for each of the sequencing platforms and other technologies used to generate the TCGA dataset.

Timeline & Milestones

The events leading up to TCGA's inception in 2006 and major milestones in the program's history.